GleamWall
中文EN

MYO MYOMO, INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1369290 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.3%
TTM net income YoY-25.4%
TTM EPS YoY-25.0%
Revenue 3-yr CAGR34.9%
Net income 3-yr CAGR—

Margins

Gross margin70.1%
Operating margin-21.8%
Net margin-33.1%
FCF margin-12.7%
EBITDA margin-18.8%

Returns

ROE-173.5%
ROA-44.4%
ROIC (approx.)-154.0%
Asset turnover1.34x

Leverage & solvency

Liabilities / assets91.9%
Debt / equity4.89x
Current ratio1.92x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.44x
Accruals ratio-25.0%
Payout ratio—
Capex / revenue-1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$12.33M$11.70M$10.11M$11.35M$10.09M$9.65M$9.83M$12.07M
Cost of revenue$3.54M$3.26M$3.21M$3.57M$3.65M$3.60M$3.22M$3.45M
Gross profit$8.79M$8.44M$6.90M$7.78M$6.44M$6.05M$6.61M$8.62M
R&D expense$1.81M$1.72M$1.62M$1.62M$1.53M$2.00M$1.79M$1.56M
SG&A expense$3.58M$3.71M$3.62M$3.43M$3.18M$3.41M$3.94M$3.60M
Operating income-$1.72M-$2.25M-$3.16M-$2.77M-$3.52M-$4.59M-$3.52M-$245,314
Pretax income-$4.13M-$3.99M-$2.82M-$3.73M-$3.53M-$4.48M-$3.33M-$175,283
Income tax$103,874$31,404$186,715$83,878$135,658$148,201$136,795$84,798
Net income-$4.23M-$4.02M-$3.01M-$3.81M-$3.66M-$4.63M-$3.47M-$260,081
EBITDA-$1.32M-$1.87M-$2.87M-$2.51M-$3.27M-$4.40M-$3.36M-$153,750
EPS (basic)-0.10-0.09-0.07—-0.09-0.11-0.08—
EPS (diluted)-0.10-0.09-0.07—-0.09-0.11-0.08—
Weighted avg. shares (diluted)43.57M42.70M42.27M—42.17M41.58M41.45M—
Balance sheet
Cash & equivalents$11.10M$11.22M$11.40M$14.13M$12.55M$14.24M$19.79M$24.37M
Short-term investments$847,027$2.23M$4.30M$4.26M$0$1.24M$4.30M$492,990
Receivables$5.92M$4.95M$4.82M$4.10M$5.29M$7.05M$4.66M$3.83M
Inventory$3.10M$3.17M$3.55M$3.12M$3.65M$4.13M$3.37M$3.17M
Current assets$23.50M$24.53M$25.66M$27.56M$22.95M$28.04M$31.10M$32.79M
PP&E, net$1.73M$1.99M$2.24M$2.21M$3.71M$2.91M$1.84M$1.33M
Total assets$33.80M$35.34M$36.75M$38.64M$34.08M$38.67M$40.87M$42.24M
Current liabilities$12.27M$10.61M$9.39M$8.35M$9.20M$11.75M$11.68M$10.17M
Short-term debt$1.79M$446,962$2.73M$0$583,333$166,667—$2.95M
Long-term debt$11.65M$11.53M$10.93M$11.22M$2.42M$1.33M—$11.22M
Total debt$13.44M$11.98M$13.66M$11.22M$3.00M$1.50M—$14.18M
Total liabilities$31.05M$29.51M$27.75M$27.23M$19.45M$21.06M$19.18M$17.53M
Shareholders' equity$2.75M$5.83M$9.00M$11.40M$14.63M$17.62M$21.69M$24.71M
Net debt$2.34M$759,999$2.26M-$2.91M-$9.55M-$12.74M—-$10.20M
Shares outstanding40.05M39.53M38.57M38.47M38.43M37.78M34.44M34.38M
Cash flow statement
Operating cash flow-$1.31M-$1.94M-$2.20M-$1.14M-$1.83M-$8.87M-$2.68M$3.37M
Capital expenditure$50,759$32,441$327,807-$1.24M$1.05M$1.26M$670,688$860,248
Free cash flow-$1.36M-$1.98M-$2.53M$98,146-$2.88M-$10.12M-$3.35M$2.51M
Investing cash flow$1.32M$2.02M-$494,345-$4.59M$189,698-$757,348-$1.90M-$1.35M
Financing cash flow-$126,947-$243,709$0$7.51M-$50,000$4.00M-$36,506$15.77M
Depreciation & amortization$405,656$384,539$291,590$263,263$246,851$190,798$158,442$91,564
Stock-based compensation$1.32M$1.04M$597,248$564,959$583,991$394,889$540,204$321,858

Free plan shows the latest 8 periods; Pro shows all 42 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.